Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02775084 · ClinicalTrials.gov registry record · NA
Fish Oil T Cell Function
A NA study of Cognitive Function and Muscle Strength, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT02775084: Completed NA study of Cognitive Function and Muscle Strength, sponsored by Texas A&M University.
NCT02775084 is a NA study of Cognitive Function and Muscle Strength that has completed, run by Texas A&M University. The registered enrollment target is 13 participants, below the 497-participant average among 20 other Cognitive Function trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02775084, a NA study of Cognitive Function and Muscle Strength, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to examine the effect of dietary n-3 polyunsaturated fatty acid supplementation on subjects' pan CD4+ T cell function, cognition, and muscle function. Half of the participants will receive fish oil, while the other half will receive a placebo (olive oil).
Primary Outcome
one blood draw on each study visit
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Fish Oil
- DIETARY_SUPPLEMENT Olive Oil
Study Locations (1)
Texas
- Texas A&M University-CTRAL - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-04 |
| Phase | NA |
What the finished NCT02775084 record still lists
NCT02775084 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 497-participant average among 20 other Cognitive Function trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Cognitive Function appearing as the primary indexed condition, and to 2 interventions - of which Fish Oil is the first listed.
NCT02775084 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02775084 about?
NCT02775084 is a clinical study titled "Fish Oil T Cell Function". The purpose of the study is to examine the effect of dietary n-3 polyunsaturated fatty acid supplementation on subjects' pan CD4+ T cell function, cognition, and muscle function. Half of the participants will receive fish oil, while the other half will receive a placebo (olive oil).
What is the current status of trial NCT02775084?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-01. Estimated completion is 2019-04.
What conditions does trial NCT02775084 study?
This clinical trial studies the following conditions: Cognitive Function, Muscle Strength.
What interventions are being tested in trial NCT02775084?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT), Olive Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02775084?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02775084 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Function
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02775084's enrollment target sits among peer trials
13 19th of 20 higher than 2 of 20 other Cognitive Function trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Function trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brain Stimulation Effects on Cognitive Task Performance
RECRUITING · NA
-
Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators
RECRUITING · NA
-
Effect of Daily Mixed Spice Consumption on Memory Function
RECRUITING · NA
-
IMST for Dementia Risk Reduction
RECRUITING · NA
-
Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia